ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed

August 20, 1976

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012